MELPHALAN AND PREDNISONE - EFFECTIVE COMBINATION FOR TREATMENT OF MULTIPLE-MYELOMA

被引：157
|
作者：
COSTA, G
ENGLE, RL
SCHILLING, A
CARBONE, P
KOCHWA, S
NACHMAN, RL
GLIDEWELL, O
机构：
[1] MED COLL VIRGINIA, DEPT MED & CLIN RES CTR, RICHMOND, VA 23298 USA
[2] NCI, MED ONCOL AREA, BETHESDA, MD 20014 USA
[3] ROSWELL PK MEM INST, ACUTE LEUKEMIA GRP B, BUFFALO, NY 14203 USA
[4] CORNELL UNIV, NEW YORK HOSP, MED CTR, DEPT MED, NEW YORK, NY 10021 USA
[5] UNIV HOSP BOSTON, DEPT MED, BOSTON, MA 02215 USA
[6] MT SINAI SCH MED, DEPT MED, NEW YORK, NY 10029 USA
来源：
AMERICAN JOURNAL OF MEDICINE | 1973年 / 54卷 / 05期
关键词：
D O I：
10.1016/0002-9343(73)90116-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：589 / 599
页数：11
相关论文
共 50 条
  • [21] HEXAMETHYLMELAMINE AND PREDNISONE IN THE TREATMENT OF REFRACTORY MULTIPLE-MYELOMA
    COHEN, HJ
    BARTOLUCCI, AA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01): : 21 - 27
  • [22] COMBINATION OF MELPHALAN AND PREDNISONE IN POOR RISK PATIENTS WITH MULTIPLE MYELOMA
    CUTTNER, J
    CANCER CHEMOTHERAPY REPORTS PART 1, 1969, 53 (01): : 84 - &
  • [23] INTERMITTENT HIGH-DOSE MELPHALAN PREDNISONE VS CONTINUOUS LOW-DOSE MELPHALAN TREATMENT IN MULTIPLE-MYELOMA
    AHRE, A
    BJORKHOLM, M
    MELLSTEDT, H
    HOLM, G
    BRENNING, G
    ENGSTEDT, L
    GAHRTON, G
    HALLEN, J
    JOHANSSON, B
    JOHANSSON, SGO
    KARNSTROM, L
    KILLANDER, A
    LERNER, R
    LOCKNER, D
    LONNQVIST, B
    SIMONSSON, B
    STALFELT, AM
    TERNSTEDT, B
    WADMAN, B
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (04): : 499 - 506
  • [24] NATURAL INTERFERON-ALPHA IN COMBINATION WITH MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA STAGE-II AND STAGE-III - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
    OSTERBORG, A
    BJORKHOLM, M
    BJOREMAN, M
    BRENNING, G
    CARLSON, K
    CELSING, F
    GAHRTON, G
    GRIMFORS, G
    GYLLENHAMMAR, H
    HAST, R
    JOHANSSON, B
    JULIUSSON, G
    JARNMARK, M
    KIMBY, E
    LERNER, R
    LINDER, O
    MERK, K
    NILSSON, B
    OHRLING, M
    PAUL, C
    SIMONSSON, B
    SMEDMYR, B
    SVEDMYR, E
    STALFELT, AM
    STRANDER, H
    UDEN, AM
    OSBY, E
    MELLSTEDT, H
    BLOOD, 1993, 81 (06) : 1428 - 1434
  • [25] MULTIPLE-MYELOMA, MELPHALAN, AND NEOPLASIA
    BARCLAY, WR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (14): : 1612 - 1612
  • [26] LUNG TOXICITY OF MELPHALAN AND STEROID COMBINATION THERAPY IN MULTIPLE-MYELOMA
    GILES, FJ
    SINGER, CRJ
    GOLDSTONE, AH
    TOBIAS, JS
    RICHARDS, JDM
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 545 - 545
  • [27] A RANDOMIZED MULTICENTRIC STUDY COMPARING ALTERNATING COMBINATION CHEMOTHERAPY (VCMP VBAP) AND MELPHALAN-PREDNISONE IN MULTIPLE-MYELOMA
    BLADE, J
    MIGUEL, JS
    ALCALA, A
    MALDONADO, J
    GARCIACONDE, J
    MORO, MJ
    SANZ, MAS
    ALONSO, C
    ZUBIZARRETA, A
    BESSES, C
    MARTIN, JMH
    BESALDUCH, J
    NIETO, LH
    CALVO, JF
    RUBIO, D
    MAYANS, JR
    SANCHIS, J
    GALINDO, RJ
    TORTOSA, J
    ORTEGA, F
    DOMINGO, A
    FAURA, MV
    DANIELS, M
    ROZMAN, C
    ESTAPE, J
    BLUT, 1990, 60 (06): : 319 - 322
  • [28] COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE, AND CARMUSTINE (BCNU) (M-2 PROTOCOL)
    TIRELLI, U
    CRIVELLARI, D
    CARBONE, A
    VERONESI, A
    GALLIGIONI, E
    TROVO, MG
    TUMOLO, S
    GRIGOLETTO, E
    CANCER TREATMENT REPORTS, 1982, 66 (11): : 1971 - 1973
  • [29] COMBINATION CHEMOTHERAPY VERSUS MELPHALAN AND PREDNISOLONE IN THE TREATMENT OF MULTIPLE-MYELOMA - AN OVERVIEW OF PUBLISHED TRIALS
    GREGORY, WM
    RICHARDS, MA
    MALPAS, JS
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) : 334 - 342
  • [30] ORAL DOSAGE OF MELPHALAN AND RESPONSE TO TREATMENT IN MULTIPLE-MYELOMA
    FERNBERG, JO
    JOHANSSON, B
    LEWENSOHN, R
    MELLSTEDT, H
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (03) : 393 - 396
12345